Q3 2024 Holdings
Filed 2024-11-14 | 71 holdings | $445.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Nuvalent Inc(NUVL) | COM | 670703107 | $38.0M | 371,441 | 8.5% |
| Merus N V | COM | N5749R100 | $31.7M | 635,439 | 7.1% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $25.4M | 347,695 | 5.7% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $21.8M | 475,555 | 4.9% |
| Erasca Inc(ERAS) | COM | 29479A108 | $19.0M | 6,946,488 | 4.3% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $18.4M | 639,840 | 4.1% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $16.0M | 470,565 | 3.6% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $13.4M | 255,578 | 3.0% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $13.2M | 1,221,362 | 3.0% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $12.2M | 167,110 | 2.7% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $11.9M | 744,592 | 2.7% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $11.4M | 901,129 | 2.6% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $11.3M | 1,099,490 | 2.5% |
| Poseida Therapeutics Inc(PSTXUSD) | COM | 73730P108 | $10.5M | 3,687,548 | 2.4% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $10.0M | 348,866 | 2.3% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $9.8M | 35,774 | 2.2% |
| Geron Corp(GERN) | COM | 374163103 | $8.2M | 1,801,561 | 1.8% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $7.3M | 378,746 | 1.6% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $6.9M | 60,500 | 1.6% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $6.7M | 574,558 | 1.5% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $6.6M | 146,657 | 1.5% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $6.5M | 1,147,891 | 1.5% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $6.4M | 51,245 | 1.4% |
| Biodesix Inc | COM | 09075X108 | $6.3M | 3,561,094 | 1.4% |
| Elutia Inc(ELUT) | CL A COM | 05479K106 | $6.3M | 1,645,808 | 1.4% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $5.7M | 1,795,080 | 1.3% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $5.6M | 5,645,352 | 1.3% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $5.4M | 455,082 | 1.2% |
| Helix Acquisition Corp II | CL A ORD SHS | G4444H101 | $5.4M | 513,369 | 1.2% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $5.3M | 461,660 | 1.2% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $5.1M | 627,552 | 1.2% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $5.1M | 103,862 | 1.1% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $5.0M | 99,566 | 1.1% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $4.9M | 145,000 | 1.1% |
| Longboard Pharmaceuticals in | COM | 54300N103 | $4.1M | 124,353 | 0.9% |
| Biogen Inc(BIIB) | COM | 09062X103 | $3.9M | 19,940 | 0.9% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $3.9M | 67,045 | 0.9% |
| Modular MED Inc(MODD) | COM NEW | 60785L207 | $3.2M | 1,440,000 | 0.7% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $3.2M | 457,739 | 0.7% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $3.1M | 26,083 | 0.7% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $3.1M | 70,516 | 0.7% |
| Mersana Therapeutics Inc | COM | 59045L106 | $3.0M | 1,585,786 | 0.7% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $3.0M | 419,242 | 0.7% |
| Tela BIO Inc(TELA) | COM | 872381108 | $2.8M | 1,124,928 | 0.6% |
| Compugen LTD(CGEN) | ORD | M25722105 | $2.7M | 1,501,113 | 0.6% |
| Cerus Corp(CERS) | COM | 157085101 | $2.6M | 1,495,329 | 0.6% |
| Zevra Therapeutics Inc(ZVRA) | COM NEW | 488445206 | $2.4M | 350,000 | 0.5% |
| Perspective Therapeutics Inc(CATX) | COM NEW | 46489V302 | $2.2M | 167,986 | 0.5% |
| Bioage Labs Inc(BIOA) | COM | 09077V100 | $2.1M | 100,000 | 0.5% |
| Unicycive Therapeutics Inc | COM | 90466Y103 | $1.6M | 4,000,000 | 0.4% |